Rephonic
Artwork for Post-Hoc Live

Post-Hoc Live

Endpoints News
FDA
Biopharma
China
Biotech
Biotechnology
Novo Nordisk
Trump Administration
Pfizer
Mergers and Acquisitions
Sarepta
Pharmaceuticals
CDC
Vaccine Policy
ACIP
Most Favored Nation Pricing
Duchenne Muscular Dystrophy
Clinical Trials
S&P Biotech Index
CRISPR Gene Editing
Moderna

Post-Hoc Live is an extension of Endpoints' analysis newsletter Post-Hoc — but streamed live on YouTube then brought to you here. Our reporters spend every day texting and calling sources, reading executive orders, and talking to each other in Slack. We're bringing that analysis that happens behind the scenes directly to you, and letting you in on some of our up-to-the-moment conversations. Subscr... more

PublishesTwice monthlyEpisodes48Foundeda year ago
Number of ListenersCategory
News

Listen to this Podcast

Artwork for Post-Hoc Live

Latest Episodes

As large pharma companies increasingly turn to China to fill their pipelines, what long-term affect will it have on their strategy and operations? Pfizer's Andrew Baum shares the large drugmaker perspective on acquisitions, R&D, and how the industry ... more

Should investors embrace China’s fast-moving, fast-growing biotech sector, or should there be barriers to protect and preserve an industry that the US has dominated for decades? Ginkgo Bioworks CEO Jason Kelly, RA Capital Management's Peter Kolchinsk... more

In a world where promising drugs are quickly copied, improved on and raced into trials, is science still a differentiator? Strand Therapeutics CEO Jake Becraft and Roivant Sciences CEO Matt Gline discussed what actually counts as innovation, and if w... more

AstraZeneca and Bristol Myers Squibb are reportedly in talks to combine, which would be one of the largest mergers the biopharma industry has ever seen. What could each company get out of the deal, and what would this deal mean for the industry overa... more

Key Facts

Accepts Guests
Accepts Sponsors
Contact Information
Podcast Host
Number of Listeners
Find out how many people listen to this podcast per episode and each month.

Similar Podcasts

People also subscribe to these shows.

Biotech Hangout
Biotech HangoutDaphne Zohar, Josh Schimmer, Brad Loncar, Tim Opler and more
Freakonomics Radio
Freakonomics RadioFreakonomics Radio + Stitcher

Recent Guests

Anna Puglisi
National Counterintelligence Officer for East Asia, ODNI; founder of Beyond Cold War Consulting
ODNI / Beyond Cold War Consulting
Episode: Are the China hawks winning?
John Stanford
Executive Director of Incubate Coalition
Incubate Coalition
Episode: Are the China hawks winning?
(no additional guests identified)
Episode: How much is everyone in biopharma getting paid?
Jeremy Levin
CEO and biotech veteran; former CEO of Teva; founder and board chair of Bio; author of Biotech and the Balance
Biotech industry veteran (Bio, Teva, Bristol-Myers Squibb, Genentech connections mentioned)
Episode: How to stabilize US biotech — with Dr. Jeremy Levin
Patrick Temple-West
FT US Pharma Correspondent
Financial Times
Episode: Makary's out: Live from the FT Summit
Elizabeth Karens
Senior Biopharma Journalist and Novo Nordisk Expert
Endpoints News
Episode: Q1 earnings recap with Endpoints News
Max Gellman
Endoints Senior Editor
Endpoints News
Episode: Q1 earnings recap with Endpoints News
David Reichsinger
Learing Partners Senior Research Analyst
Learing Partners
Episode: Q1 earnings recap with Endpoints News
Brinda Adhikari
Host of Why Should I Trust You; public health journalist
CBS News / Why Should I Trust You
Episode: Trust, MAHA, and what’s next for the CDC

Hosts

Drew Armstrong
Executive Editor of Endpoints News; host and primary moderator for live analysis and discussion
Max Bayer
Biotech reporter and co-host; covers vaccine, manufacturing, and deal dynamics

Chart Rankings

How this podcast ranks in the Apple Podcasts, Spotify and YouTube charts.

Apple Podcasts
#198
South Korea/News

Talking Points

Recent interactions between the hosts and their guests.

How much is everyone in biopharma getting paid?
Q: How do you explain the components that go into a CEO pay package?
The package is almost entirely equity-based, including restricted stock, stock options, and performance-based awards that vest or depend on hitting goals, with 90-99% of pay typically in at-risk forms.
The spring deals bonanza
Q: Emily, where does the firepower come from for these big deals, and how is it sustained in a high-rate environment?
Emily explains that large pharma players have accumulated substantial war chests and access to capital, enabling continued dealmaking despite higher interest rates, while discussing how management teams view value, premiums, and risk in ongoing negotiations.
The spring deals bonanza
Q: Emily, welcome to the show. Will you tell us just like about your job?
Emily Field describes her role overseeing US Biopharmaceuticals Equity Research at Barclays, covering large-cap drug developers with significant M&A and pipelines, and explaining how her team analyzes the strategic value and risk of potential acquisitions.
How to stabilize US biotech — with Dr. Jeremy Levin
Q: If you were starting a new biotech company today, where would you build it and how would you structure it for success?
Levin says build in the United States for innovation, but forge global partnerships, particularly with China and other countries, to leverage faster development and lower costs while protecting strategic interests.
How to stabilize US biotech — with Dr. Jeremy Levin
Q: Why did you decide to write Biotech in the Balance, and what are the core concerns you address?
He argues that without decisive action in the industry, American biotech could suffer a major setback; the book analyzes the infrastructure of biotech, including NIH funding, academia, and capital markets, and calls for structural changes to sustain innovation.

Audience Metrics

Listeners, social reach, demographics and more for this podcast.

Listeners per Episode
Gender Skew
Location
Interests
Professions
Age Range
Household Income
Social Media Reach

Frequently Asked Questions About Post-Hoc Live

What is Post-Hoc Live about and what kind of topics does it cover?

This show centers biotech policy, regulatory dynamics, and the business of biopharma, often framing issues through live, panel-style discussions with reporters, investors, executives, and policy experts. Episodes frequently explore China's role in biotech, FDA and NIH policy, funding and capital markets, and the evolving landscape of drug development, pricing, and access. A recurring strength is translating complex regulatory and policy shifts into practical implications for investors, industry players, and patients, with lively debates around public trust, regulatory reform, and strategic positioning in a rapidly changing ecosystem. Notable is the willingness to host cross-cutting perspectives from journalists, industry insiders, and gover... more

Where can I find podcast stats for Post-Hoc Live?

Rephonic provides a wide range of podcast stats for Post-Hoc Live. We scanned the web and collated all of the information that we could find in our comprehensive podcast database. See how many people listen to Post-Hoc Live and access YouTube viewership numbers, download stats, audience demographics, chart rankings, ratings, reviews and more.

How many listeners does Post-Hoc Live get?

Rephonic provides a full set of podcast information for four million podcasts, including the number of listeners. View further listenership figures for Post-Hoc Live, including podcast download numbers and subscriber numbers, so you can make better decisions about which podcasts to sponsor or be a guest on. You will need to upgrade your account to access this premium data.

What are the audience demographics for Post-Hoc Live?

Rephonic provides comprehensive predictive audience data for Post-Hoc Live, including gender skew, age, country, political leaning, income, professions, education level, and interests. You can access these listener demographics by upgrading your account.

How many subscribers and views does Post-Hoc Live have?

To see how many followers or subscribers Post-Hoc Live has on Spotify and other platforms such as Castbox and Podcast Addict, simply upgrade your account. You'll also find viewership figures for their YouTube channel if they have one.

Which podcasts are similar to Post-Hoc Live?

These podcasts share a similar audience with Post-Hoc Live:

1. BioCentury This Week
2. Biotech Hangout
3. The Readout Loud
4. Freakonomics Radio
5. Planet Money

How many episodes of Post-Hoc Live are there?

Post-Hoc Live launched a year ago and published 48 episodes to date. You can find more information about this podcast including rankings, audience demographics and engagement in our podcast database.

How do I contact Post-Hoc Live?

Our systems regularly scour the web to find email addresses and social media links for this podcast. We scanned the web and collated all of the contact information that we could find in our podcast database. But in the unlikely event that you can't find what you're looking for, our concierge service lets you request our research team to source better contacts for you.

Where can I see ratings and reviews for Post-Hoc Live?

Rephonic pulls ratings and reviews for Post-Hoc Live from multiple sources, including Spotify, Apple Podcasts, Castbox, and Podcast Addict.

View all the reviews in one place instead of visiting each platform individually and use this information to decide if a show is worth pitching or not.

How do I access podcast episode transcripts for Post-Hoc Live?

Rephonic provides full transcripts for episodes of Post-Hoc Live. Search within each transcript for your keywords, whether they be topics, brands or people, and figure out if it's worth pitching as a guest or sponsor. You can even set-up alerts to get notified when your keywords are mentioned.

What guests have appeared on Post-Hoc Live?

Recent guests on Post-Hoc Live include:

1. Anna Puglisi
2. John Stanford
3. (no additional guests identified)
4. Jeremy Levin
5. Patrick Temple-West
6. Elizabeth Karens
7. Max Gellman
8. David Reichsinger

To view more recent guests and their details, simply upgrade your Rephonic account. You'll also get access to a typical guest profile to help you decide if the show is worth pitching.

Find and pitch the right podcasts

We help savvy brands, marketers and PR professionals to find the right podcasts for any topic or niche. Get the data and contacts you need to pitch podcasts at scale and turn listeners into customers.
Try it free for 7 days